The future of salvage therapy: monitoring systems for patient outcomes: (a personal take on Panel 3. Discussion leader: Douglas Ward).(Essays)

From: Research Initiative/Treatment Action! | Date: June 22, 2004| Author: Sharp, Matt | Copyright information

In looking to the future of salvage therapy, consideration must be given to what treatment strategies will work best, what the salvage population will look like, what types of patients will be available for trials of new drugs, and what resources will be available to provide the new drugs. Will multi-drug resistance (MDR) of the virus occur with the treatment regimens used today? How can research provide answers for how to circumvent MDR? These were the topics discussed in Panel 3, ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

The future of salvage therapy: monitoring systems for patient outcomes: (a personal take on Panel 3. Discussion leader: Douglas Ward).(Essays)
Research Initiative/Treatment Action! ; In looking to the future of salvage therapy, consideration must be given to what treatment strategies will work best, what the salvage population will look like, what types of patients will be available for trials of new drugs, and what resources will be available to provide the new drugs. Will
Letter from the editor.(Editorial)
Research Initiative/Treatment Action! ; DEAR READER Salvage is an ugly word. Saying it by itself, one thinks of a large yard with rusting heaps of old appliances or dismantled cars that once had use and purpose in our modern world. Salvage can also refer to the rescue of a ship from a shipwreck, fire, or other destruction. So, how in the
TIBOTEC GETS AIDS
Pharmaceutical Executive ; With a new wave of "resistant to resistance" HIV drugs, a record of consistent innovation, and a dynamic partnership with AIDS activists, J&J's little company is in it to win it. And end it. BY WALTER ARMSTRONG in the war against AIDS, the chid enemy these clays is resistance. Two decades after
Triple PI therapy for salvage.(Treatment News)(Brief Article)
HIV Treatment: ALERTS! ; Researchers report in the Journal of Acquired Immune Deficiency Syndromes (36, p. 921, 2004) that an HIV treatment consisting of 3 protease inhibitors (PIs) may help salvage patients. These patients require new types of treatments because they have taken many HIV medications in the past and their
Regulatory issues and challenges in salvage therapy: (a personal take on Panel 4. Discussion leader: Trip Gulick).
Research Initiative/Treatment Action! ; Panel 4 focused on how regulatory issues were presently affecting options for salvage patients. Initial discussion noted that the numerous changes and improvements made at the Food and Drug Administration (FDA) over the last 20 years, often as a result of community input and pressure, have